New Zealand Pharmaceuticals & Biotech High Insider Buying

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

2 companies

Pacific Edge

Market Cap: NZ$335.3m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

PEB

NZ$0.27

8.0%

167.3%

Rua Bioscience

Market Cap: NZ$13.6m

Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.

RUA

NZ$0.04

2.6%

-13.0%